2-count Heat Patches
NDC Package 68016-067-02
Package Information
2-count Heat Patches is for Use on Adults and Childrens 12 Years of Age or OlderClean and dru affected area; ensure area is fully dry before applicationRemove patch from filmApply to treatement sitePatch may be trimmerd to best fit treatment site; trim patch before removing filmWash hands after applicationDiscard after signle useCaution:Take care when using on elderly ot incapacited personsDo not use more than 8 hoursDo not use the Capsaicin Heat Patch more than 3-4 times dailyDo not exceed 7 days of continue use. Marketed by Chain Drug Consortium, Llc, this product is identified by NDC 68016-067 and is authorized under FDA application part348.
Identification & Billing
- RxCUI: 1043399 - capsaicin 0.025 % Medicated Patch
- RxCUI: 1043399 - capsaicin 0.00025 MG/MG Medicated Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68016 - Chain Drug Consortium, Llc
- 68016-067 - 2-count Heat Patches
- 68016-067-02 - 2 PATCH in 1 BOX / 9 g in 1 PATCH
- 68016-067 - 2-count Heat Patches
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68016-067-02 identifies a specific commercial package of 2 patch in 1 box / 9 g in 1 patch of 2-count Heat Patches, labeled by Chain Drug Consortium, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Consortium, Llc on June 01, 2017. The current certification is valid through December 31, 2024.
How is this Chain Drug Consortium, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68016006702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.